Literature DB >> 18463921

Patterns of healthcare utilization by COPD severity: a pilot study.

Min J Joo1, Todd A Lee, Brian Bartle, William B van de Graaff, Kevin B Weiss.   

Abstract

Global Initiative on Chronic Obstructive Lung Disease (GOLD) guidelines recently removed stage 0, a group with symptoms but without airways obstruction, from their severity staging. However, in practice this group may still be diagnosed and medically managed. The aim of this study was to characterize healthcare utilization patterns of chronic obstructive pulmonary disease (COPD) patients by disease severity, focusing on the possible unique attributes of patients who would have been classified as GOLD stage 0. This is a prospective cohort pilot study performed at the Hines Veterans Administration Hospital. One hundred twenty patients with a diagnosis of COPD were enrolled. The participants completed quality-of-life questionnaires and a pulmonary function test. Healthcare utilization data were obtained 1 year prior and 2 years after the enrollment date. Three disease severity groups were defined based on GOLD criteria for comparison [GOLD stage 1-2 (GS 1-2), GOLD stage 3-4 (GS 3-4), and formerly GOLD stage 0 ("at risk")]. The "at risk" group had an average of 14.4 (SD = 30.5) outpatient visits/year and 0.3 (SD = 0.8) hospitalizations/year, which were higher than the other groups, but this was not statistically significant. Respiratory medications were used by 6 (26%), 30 (59%), and 40 (91%) patients from "at risk" to GS 3-4, respectively. Patients in the "at risk" group had a decrement in health status, significant utilization of healthcare services, and were often receiving medications not consistent with guidelines.

Entities:  

Mesh:

Year:  2008        PMID: 18463921     DOI: 10.1007/s00408-008-9095-5

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  17 in total

Review 1.  Controversies in the use of spirometry for early recognition and diagnosis of chronic obstructive pulmonary disease in cigarette smokers.

Authors:  P L Enright; R O Crapo
Journal:  Clin Chest Med       Date:  2000-12       Impact factor: 2.878

2.  A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire.

Authors:  P W Jones; F H Quirk; C M Baveystock; P Littlejohns
Journal:  Am Rev Respir Dis       Date:  1992-06

3.  Can global initiative for Chronic Obstructive Lung Disease stage 0 provide prognostic information on long-term mortality in men?

Authors:  Knut Stavem; Leiv Sandvik; Jan Erikssen
Journal:  Chest       Date:  2006-08       Impact factor: 9.410

4.  Spirometry use in clinical practice following diagnosis of COPD.

Authors:  Todd A Lee; Brian Bartle; Kevin B Weiss
Journal:  Chest       Date:  2006-06       Impact factor: 9.410

5.  Ten-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohort.

Authors:  Anne Lindberg; Ann-Christin Jonsson; Eva Rönmark; Rune Lundgren; Lars-Gunnar Larsson; Bo Lundbäck
Journal:  Chest       Date:  2005-05       Impact factor: 9.410

6.  American translation, modification, and validation of the St. George's Respiratory Questionnaire.

Authors:  J T Barr; G E Schumacher; S Freeman; M LeMoine; A W Bakst; P W Jones
Journal:  Clin Ther       Date:  2000-09       Impact factor: 3.393

7.  An empirical comparison of the St George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting.

Authors:  M Rutten-van Mölken; B Roos; J A Van Noord
Journal:  Thorax       Date:  1999-11       Impact factor: 9.139

8.  Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  David M Mannino; Dennis E Doherty; A Sonia Buist
Journal:  Respir Med       Date:  2006-01       Impact factor: 3.415

9.  Spirometry utilization for COPD: how do we measure up?

Authors:  Meilan K Han; Min Gayles Kim; Russell Mardon; Phil Renner; Sean Sullivan; Gregory B Diette; Fernando J Martinez
Journal:  Chest       Date:  2007-06-05       Impact factor: 9.410

10.  Health-related quality of life is related to COPD disease severity.

Authors:  Elisabeth Ståhl; Anne Lindberg; Sven-Arne Jansson; Eva Rönmark; Klas Svensson; Fredrik Andersson; Claes-Göran Löfdahl; Bo Lundbäck
Journal:  Health Qual Life Outcomes       Date:  2005-09-09       Impact factor: 3.186

View more
  8 in total

1.  Observational study of inhaled corticosteroids on outcomes for COPD patients with pneumonia.

Authors:  Dennis Chen; Marcos I Restrepo; Michael J Fine; Mary Jo V Pugh; Antonio Anzueto; Mark L Metersky; Brandy Nakashima; Chester Good; Eric M Mortensen
Journal:  Am J Respir Crit Care Med       Date:  2011-04-21       Impact factor: 21.405

2.  Burden of COPD in a government health care system: a retrospective observational study using data from the US Veterans Affairs population.

Authors:  Amir Sharafkhaneh; Nancy J Petersen; Hong-Jen Yu; Anand A Dalal; Michael L Johnson; Nicola A Hanania
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-05-06

3.  Health care utilization history, GOLD guidelines, and respiratory medication prescriptions in patients with COPD.

Authors:  Joseph Seaman; Anthony C Leonard; Ralph J Panos
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-04-07

Review 4.  A Systematic Literature Review of the Humanistic Burden of COPD.

Authors:  John R Hurst; Mohd Kashif Siddiqui; Barinder Singh; Precil Varghese; Ulf Holmgren; Enrico de Nigris
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-05-10

5.  Comparison of health-related quality of life measures in chronic obstructive pulmonary disease.

Authors:  A Simon Pickard; Yoojung Yang; Todd A Lee
Journal:  Health Qual Life Outcomes       Date:  2011-04-18       Impact factor: 3.186

6.  Efficacy of indacaterol 75 μg versus fixed-dose combinations of formoterol-budesonide or salmeterol-fluticasone for COPD: a network meta-analysis.

Authors:  Shannon Cope; Matthias Kraemer; Jie Zhang; Gorana Capkun-Niggli; Jeroen P Jansen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-07-05

7.  Impact of statins and ACE inhibitors on mortality after COPD exacerbations.

Authors:  Eric M Mortensen; Laurel A Copeland; Mary Jo V Pugh; Marcos I Restrepo; Rosa Malo de Molina; Brandy Nakashima; Antonio Anzueto
Journal:  Respir Res       Date:  2009-06-03

8.  Patterns and determinants of COPD-related healthcare utilization by severity of airway obstruction in Korea.

Authors:  Kyungsoo Chung; Kyungjoo Kim; Jiye Jung; Kyungwon Oh; Yeonmok Oh; Sekyu Kim; Jinhee Kim; Youngsam Kim
Journal:  BMC Pulm Med       Date:  2014-02-27       Impact factor: 3.317

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.